Please select an option below to help us tailor your newsletter to best suit your content interests!
Our West network is 1st in the Mid-South to offer gynecologic brachytherapy using the Geneva™ Applicator! This advanced technology is used to treat certain gynecologic cancers with more precision, while also helping protect nearby healthy tissue. What is Brachytherapy? Brachytherapy is a type of radiation treatment that delivers radiation directly to the area where cancer… Read more »
Dr. Gregory Vidal was recently featured by the American Society of Clinical Oncology (ASCO), highlighting the critical role federal funding plays in advancing cancer research. As both a medical oncologist and clinical researcher, Dr. Vidal sees firsthand how continued investment in research helps fuel new discoveries, expand access to innovative treatments, and ensure tomorrow’s breakthroughs… Read more »
In a new article highlighting the importance of inclusive clinical research, we have been recognized as 1 of the 4 inaugural sites of Genentech‘s Advancing Inclusive Research® (AIR) Site Alliance. The article highlights how our research team identified an eligibility requirement in a breast cancer study that was disproportionately excluding Black women. Our team’s feedback helped… Read more »
Join us for Best of ASCO®: Memphis on August 8–9 at the Hilton Memphis for two days of the latest advances in oncology, expert-led education, and 8.5 CME credits — registration is FREE! We’re especially proud that two of our own oncologists will be presenting: 🔹 Dr. Axel Grothey – Non-Colorectal Cancer 🔹 Dr. Jason… Read more »
We are so proud to announce the launch of a groundbreaking clinical study with IceCure Medical, making our network the 1st U.S. clinical site for the company’s ProSense® cryoablation technology. The ChoICE Study will evaluate the use of ProSense® cryoablation in low-risk breast cancer patients, enrolling approximately 400 patients across 30 clinical sites nationwide. This important research… Read more »
Dr. Axel Grothey will present new research at this year’s ESMO – European Society for Medical Oncology – Gastrointestinal Cancer Congress in Munich, Germany, highlighting an innovative approach to improving diagnosis for patients with carcinoma of unknown primary (CUP) and other diagnostically complex cancers. As lead investigator, Dr. Grothey collaborated with West providers Heather Greene,… Read more »
We are proud to announce that West will be the 1st cancer center in the Mid‑South to offer Daraxonrasib, a next‑generation targeted therapy representing one of the most significant advances in pancreatic cancer treatment in years. Daraxonrasib is designed to interrupt key cancer‑driving pathways associated with some of the most aggressive forms of pancreatic cancer. Early clinical data has shown meaningful improvements in tumor response,… Read more »
We’re excited to share that Dr. Michael Doherty, our Director of Interventional Radiology, has been featured in the latest issue of Memphis Health & Fitness magazine! In the feature, Dr. Doherty discusses innovative minimally invasive procedures that can help treat knee pain, back pain, plantar fasciitis, inflammation, and other conditions—often with less downtime and without… Read more »
Join Us for the 2026 Best of ASCO Memphis Conference Join us for the upcoming “2026 Best of ASCO Memphis Conference,” taking place Saturday and Sunday, August 8–9, 2026, at the Hilton Memphis Hotel. This highly anticipated event brings together oncology professionals from across the region for a weekend of collaboration, education, and practical clinical… Read more »
NEW BARTLETT CAMPUS We are excited to announce the expansion of our network with a new Bartlett location, bringing expert surgical care even closer to patients in the surrounding community. This new location is designed with your convenience in mind – making it easier to receive high-quality, specialized care without having to travel far. Patients… Read more »